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Background: Assessment of comorbid personality disorders (PDs) in patients with substance use disorders (SUDs) is
challenging due to symptom overlap, additional mental and physical disorders, and limitations of the assessment
methods. Our in-depth study applied methods to overcome these difficulties.
Method: A complete catchment area sample of 61 consecutively admitted patients with SUDs, with no previous
history of specialized treatment (addiction clinics, psychiatry) were studied, addressing PDs and associated clinical
and demographic variables. The thorough assessments included the Psychiatric Research Interview for Substance
and Mental Disorders and the Structured Clinical Interview for DSM-IV Axis II Personality Disorders.
Results: Forty-six percent of the SUD patients had at least one PD (16% antisocial [males only]; 13% borderline; and
8% paranoid, avoidant, and obsessive-compulsive, respectively). Cluster C disorders were as prevalent as Cluster B
disorders. SUD patients with PDs were younger at the onset of their first SUD and at admission; used more illicit
drugs; had more anxiety disorders, particularly social phobia; had more severe depressive symptoms; were more
distressed; and less often attended work or school.
Conclusion: The psychiatric comorbidity and symptom load of SUD patients with PDs differed from those of SUD
patients without PDs, suggesting different treatment needs, and stressing the value of the assessment of PDs in
SUD patients.
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Personality disorders (PDs) are among the most preva-
lent comorbid disorders in treatment-seeking patients
with substance use disorders (SUDs). Studies of outpati-
ents with alcohol use disorders (AUDs) have found a
prevalence of PDs between 40% and 64% [1-4]. In sam-
ples of inpatients with AUD, the prevalence ranges from
34% to 78% [5-7]. In studies that include drug use disor-
ders (DUDs), the prevalence has been found to be
between 35% and 91% [7-13]. Studies suggest antisocial
PD and borderline PD to be the most prevalent PDs in* Correspondence: anne-marit.langas@vestreviken.no
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reproduction in any medium, provided the orSUD subjects by a wide margin, comprising up to 33.5%
and 27.7% of samples, respectively [13]. Therefore, many
studies have only included the assessment of antisocial
PD or antisocial and borderline PDs. However, some
studies have found other PDs to be more prevalent. In a
sample of inpatients with AUD, Preuss et al. found that
obsessive-compulsive, borderline, narcissistic, and para-
noid disorders, in that order, were the most prevalent
PDs [6]. In a sample of AUD outpatients, Echeburua
et al. found obsessive-compulsive, antisocial, paranoid,
and dependent PDs to be the most prevalent [3]. In an-
other sample of AUD outpatients, borderline PD, PD
not otherwise specified (NOS), narcissistic PD, and
obsessive-compulsive PD were the most prevalent [4]. In
DeJong et al.’s study, the order of PDs with the highest
prevalence in AUD patients was histrionic, dependent,
avoidant, and compulsive, while the order in DUDLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and antisocial [7].
As substance use, mental disorders, and physical dis-
eases have many overlapping symptoms, it is difficult to
decide to which disorder a symptom should be attribu-
ted in patients with multiple disorders. Reliable PD diag-
noses in SUD patients can only be achieved when the
interviewer is aware of the comorbid disorders and has
the necessary clinical skills to disentangle the disorders
from each other, preferably guided by an interview
designed for this purpose. A symptom should not be
attributed to a PD if it only occurs during heavy sub-
stance use, withdrawal, or an active phase of an Axis I
disorder. In addition, the Diagnostic and Statistical Man-
ual of Mental Disorders, Fourth Edition, Text Revision
[14] states that a PD should not be based “. . .solely on
behaviors that are consequences of Substance Intoxica-
tion or Withdrawal or that are associated with activities
in the service of sustaining a dependency (e.g., antisocial
behavior)” (DSM-IV-TR page 688–689). Some persona-
lity changes, such as antisocial or paranoid features, are
common after long-term heavy substance abuse. In con-
trast to the DSM-IV, the World Health Organization’s
ICD-10 Classification of Mental and Behavioral Disor-
ders, includes the possibility of a substance-induced
change in personality [15].
The association between SUDs and PDs is not simply
the result of diagnostic methodology or symptom over-
lap. Verheul et al. found that PDs did not remit with
SUD remission after SUD treatment [16]. Rounsaville
et al. differentiated between primary and substance-
induced symptoms of PD diagnoses, but the prevalence
of PD diagnoses without substance-related symptoms
was still high [9]. Skodol et al. found that the prevalence
of PD was as high in patients with past SUDs as in
patients with present SUDs [17].
It is important to clarify any differences between SUD
patients with PDs and those without. Studies suggest
that SUD patients with PDs are younger, have lower
levels of education, are less likely to be married, are
more likely to abuse illegal substances, have a different
pattern of alcohol use, have more psychopathology, in-
cluding anxiety and depression, are more impulsive, and
are less satisfied with life [12,18]. One study, however,
found no substantial differences apart from more anxiety
and depression in the SUD patients with PDs [10].
In conclusion, previous studies of PDs in SUD patients
have some limitations: the selection of convenience sam-
ples, the mixture of patients with different treatment
histories, the use of lay interviewers, and the application
of diagnostic interviews of nonoptimal validity and reli-
ability in comorbid SUD, Axis I, or Axis II disorders. No
studies based on catchment-area samples of patients ad-
mitted for the first time have been published.Norwegian psychiatric and addiction services are pub-
lic, based on catchment areas and are available to every-
one. Almost all patients with mental or addiction
problems are primarily referred to the psychiatric de-
partment of the local hospital for their catchment area.
This allowed us to study a sample of all patients with
SUDs consecutively admitted to specialist psychiatric or
addiction services for the first time within a specified
time period from one catchment area.
Our null hypotheses were: 1) The only prevalent and
clinically relevant PDs in SUD patients entering treat-
ment for the first time are antisocial PD and borderline
PD, and 2) there are no differences between first-time
admitted SUD patients with and without PDs in demo-
graphics, comorbidity, symptoms, or functioning.
Methods
Participants
All patients with SUDs from the catchment area who
were 16 years and older, had no previous history of adult
specialized addiction or psychiatric treatment, and were
consecutively admitted to inpatient or outpatient treat-
ment within a period of 18 months were included.
The catchment area was a rural area in southeastern
Norway. The main town is situated 82 km from Norway’s
capital, Oslo. All commonly used legal and illegal sub-
stances were available. Patients referred for addiction
treatment were presumed to have an SUD and were
asked to give their consent to participate in the study.
Patients referred for psychiatric treatment were screened
for substance use problems using the Alcohol Use Disor-
ders Identification Test (AUDIT) [19] and the Drug Use
Disorders Identification Test (DUDIT) [20]. The chosen
cutoffs were scores of six (females) and eight (males) for
the AUDIT, and two (females) and six (males) for the
DUDIT. Patients who scored above the cutoff were asked
for their consent and referred to the study.
The included patients were required to be cooperative
in the study. All patients were assessed in a stable state
of their SUDs and other Axis I disorders, so that Axis I
symptoms did not interfere with the Axis II judgment.
Because most SUD patients in Norway are assessed as
outpatients before they are referred to inpatient treat-
ment, most of the sample patients were outpatients.
Only five were inpatients, and three of these were inpati-
ents only during parts of their assessment period.
Of the 93 patients identified by their therapists as ful-
filling the inclusion criteria, 78 gave their written con-
sent to take part in the study. Of the 15 patients who
refused to take part, six were male and nine were female,
their mean age was 30.1 years, and all had alcohol as
their main substance of abuse. In addition, one patient
abused cannabis and one patient abused sedatives. Of
the 78 patients who gave their consent, four dropped
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and their mean age was 23.8 years. Three of them had
polysubstance dependence. Data for the fourth were not
available. Altogether, 74 patients accomplished all or
most of the assessments, but of these, one gave unreli-
able data because of an organic brain disorder. Of the 73
included patients, 12 (16.4%) did not fulfill the diagnos-
tic criteria for any SUD diagnosis (that is, dependence or
abuse) despite positive screening. The analyses presented
here were carried out on the 61 patients with one or
more SUD diagnoses.
Measurements
Demographics, family history of mental disorders and
SUDs, and basic data about general health were regis-
tered with the shortened version of the Stanley Founda-
tion’s Network Entry Questionnaire (NEQ) [21]. We
collected information about physical health, as well as
extensive blood samples, to test for somatic causes of
the symptoms.
The substance use history, SUDs, other Axis I disor-
ders, age at onset, and time periods where the diagnostic
criteria for a disorder were fulfilled were assessed with
the Psychiatric Research Interview for Substance and
Mental Disorders (PRISM) for DSM-IV [22,23]. This
interview was designed in accordance with the DSM-IV
criteria for differentiating between independent and
substance-induced disorders, and includes instructions
for the identification and exclusion of expected effects of
substance intoxication or withdrawal. A clinically experi-
enced psychiatrist (first author), who had attended
PRISM training arranged by the group at Columbia Uni-
versity, where the interview was developed, performed
all the PRISM interviews.
Personality disorders were assessed with the Struc-
tured Clinical Interview for DSM-IV Axis II Personality
Disorders (SCID-II). The SCID-II is an instrument with
good reliability for diagnosing PDs [24]. A psychiatrist
experienced in SUD and PD diagnostics, and formally
trained in reliable and valid SCID-II interviewing at the
Department of Personality Psychiatry, Oslo University
Hospital (first author), performed all SCID-II interviews.
The SCID-II interview was performed after the PRISM,
and the interviewer was aware of the patients’Axis I dis-
orders. Throughout the SCID-II interview, each patient
was reminded several times not to include symptoms
restricted to periods of heavy substance use, withdrawal,
or other Axis I disorders.
The categorical PD diagnoses, based on a specific number
of criteria for each diagnosis, have some limitations. The Per-
sonality and Personality Disorders Work Group for the
DSM-5 has recommended a significant reformulation of the
approach to the assessment and diagnosis of personality psy-
chopathology: a hybrid dimensional-categorical model [25].These recommendations were not available at the time of
our data collection. Therefore, we included the group of PD
patients with subthreshold diagnoses in the PD diagnosis
group in our analyses. We defined subthreshold as one cri-
terion short of the diagnostic criteria for each diagnosis
according to the DSM-IV. By including the subthreshold
cases, we were able to explore whether the severity or di-
mensional aspect of PDs, measured by the number of cri-
teria, influenced the results. The PDs described in Appendix
B of the DSM-IV (depressive PD and passive-aggressive
[negativistic] PD) were not included in this study.
The Global Assessment of Functioning (GAF) split
version was used for the overall assessment of symptoms
and functioning. The first author carried out the GAF
assessment. She had taken part in several GAF rating
exercises with experienced raters. Previous studies of the
reliability of the GAF indicate that GAF scores assigned
by raters in research situations are reliable provided
there is sufficient interrater training [26]. Both symptom
and function scores of the GAF were consistent across
experienced raters [27].
We applied the revised version of the 90-question
Symptom Checklist (SCL-90-R) [28] as a screening instru-
ment for psychiatric symptoms. Studies have shown that
the SCL-90 has high sensitivity and moderate specificity
when used as a screening instrument for mental disorders
in SUD patients [29,30]. The sum score, the Global Sever-
ity Index, can be used as a measure of overall psycho-
logical distress. The nine subscales may not be considered
to reflect separate independent dimensions [31].
Depressive symptoms were further investigated with
the Inventory of Depressive Symptoms (IDS) [32]. The
IDS interviews were performed by the first author, who
had attended reliability training with the following
results: ICC = 0.97 [95% CI: 0.87–0.99], or a nurse spe-
cialized in clinical psychiatry. She underwent a training
course and completed the first three interviews under
the supervision of the first author.
We did not divide the SUD diagnoses into ‘abuse’ or
‘dependence’ for analysis, in accordance with the sugges-
tion by the DSM-5 Work Group [25]. AUD and DUD
are the subgroups of SUDs included in our study, where
DUD covers abuse of or dependence on illicit drugs or
prescribed medications with misuse potential. We use
the terms ‘AUD only’ to refer to AUD without DUD, and
‘DUD only’ to refer to DUD without AUD.
The age at onset of a disorder was defined as the age
at which the patient met the full criteria of the diagnosis.
The duration of an untreated disorder was defined as
the sum of all periods in which the patient met the full
criteria of the disorder until first admission to specia-
lized health services.
More details of the methods have been described in an
earlier publication [33]. The study received approval
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Medical Ethics (REC, reference number 109-08072d
6.2008.100), and from the Norwegian Social Science Data
Services. The study complies with the Helsinki Declaration.
Statistical analysis
SPSS software (PASWW Statistics version 16.0; IBM,
Armonk, NY, USA), was used for the analyses. Statistical
significance was determined using the 0.05 level and
two-tailed tests of significance. Chi-square tests with
continuity correction or Fisher’s exact tests were used to
investigate group differences on categorical data. Inde-
pendent sample t-tests were used to compare groups
on normally distributed continuous variables. Mann–
Whitney U tests were used to compare groups on con-
tinuous variables that were not normally distributed.
Results
Demographics
The demographic data for SUD patients with and without
comorbid PDs are shown in Table 1. One-third of the
sample was female, with no statistically significant differ-
ence between groups. SUD patients with PDs had a lower
age at admission and less education, and attended school
or work less often than SUD patients without PDs.
Prevalence of PDs
Of the 61 patients with one or more lifetime SUDs, 28
(46%) had one or more PD diagnoses: 21 had one PD,
three had two PDs, three had three PDs, and one had
four PDs. Table 2 shows the prevalence of the different
PDs and the total numbers within clusters. We found
numerically more patients in Cluster B (21%) than Clus-
ter C (18%) or Cluster A (8%).
Antisocial PD (16%) and borderline PD (13%) were the
most prevalent disorders. Paranoid, avoidant, obsessive-
compulsive, and PD NOS were equally prevalent (8%
each). Schizotypal and dependent PD were found in one
patient each. None of the patients in our sample met theTable 1 Demographics in first-admission patients with substa
PD full criteria
Yes No
n = 28 n = 33
Demographics
Age at admission (mean years) 27.4 34.9
Female (%) 29 36
Education (mean years) 11.2 12.9
Married/cohabiting (%) 39 24
Work or school (%) 21 61
Notes. * p < 0.05; ** p < 0.01; *** p ≤ 0.001.
PD personality disorder, Subthreshold lacking one criterion for the diagnosis, Sign. stfull criteria for schizoid, narcissistic, or histrionic PD.
Table 2 also shows the prevalence of disorders when
subthreshold diagnoses were included. We found that
57% of the patients had a PD or subthreshold PD, with
more patients in Cluster C than in Cluster B. Obsessive-
compulsive PD was as prevalent as antisocial PD (20%).
Comparison of the prevalence of PDs in male and fe-
male patients showed a significant difference only in anti-
social PD. None of the female patients had antisocial PD,
but 24% of the males did (p = 0.023). When we compared
AUD-only patients with patients who had DUD with or
without additional AUD, we found significantly more PDs
in the DUD group (74% versus 29%, p = 0.025).SUDs
Of the total sample, 53 patients (87%) had AUD and 33
patients (54%) had DUD. Twenty-eight patients (46%)
had AUD only and eight patients (13%) had DUD only.
Twenty-five patients (41%) had both AUD and DUD.
The 33 patients with DUD abused or were dependent on
the following substances (number of patients in paren-
theses): cannabis (28), sedatives (13), stimulants (10), co-
caine (9), opioids (2), and other substances (2). Of the
polysubstance users, 10 patients had two SUDs, 10
patients had three SUDs, three patients had four SUDs,
and four patients had five SUDs.
Table 3 shows the different SUDs in SUD patients with
and without PDs. Patients without PDs more often had
AUD only, while patients with PDs more often had both
AUD and DUD. The higher DUDIT score in SUD
patients with PDs also confirmed the more prevalent use
of illicit drugs, especially cannabis and stimulants. The
PD group smoked about twice as many nicotine cigar-
ettes per day on average. These patients also showed
other signs of more serious substance use problems; they
had an earlier age of onset of their first SUD, longer total
duration of SUDs before admission to treatment, and a
higher number of SUD diagnoses.nce use disorders, with and without personality disorders
PD including subthreshold diagnoses
Sign. Yes No Sign.
n = 35 n = 26
* 27.4 36.8 *
29 39
*** 11.7 12.8 *
37 23
** 29 62 *
atistically significant differences between patients with and without PD.
Table 2 Prevalence of different personality disorders in patients admitted for the first time with substance use
disorders
PD full criteria PD including subthreshold diagnoses
n (%) n (%)
Any Cluster A 5 (8) 12 (20)
Paranoid 5 (8) 11 (18)
Schizoid 0 1 (2)
Schizotypal 1 (2) 1 (2)
Any Cluster B 13 (21) 17 (28)
Antisocial 10 (16) 12 (20)
Borderline 8 (13) 10 (16)
Histrionic 0 1 (2)
Narcissistic 0 0
Any Cluster C 11 (18) 19 (31)
Avoidant 5 (8) 8 (13)
Dependent 1 (2) 4 (7)
Obsessive-compulsive 5 (8) 12 (20)
PD NOS 5 (8) na
Any PD 28 (46) 35 (57)
Notes. Subthreshold diagnoses lacking one criterion for the diagnosis. Some patients have more than one PD within the same cluster. Some patients have PDs from
more than one cluster; NOS not otherwise specified, na not applicable.
Table 3 Substance use disorders and other substance use assessments in patients with and without comorbid
personality disorders
PD full criteria PD including subthreshold diagnoses
Yes No Sign. Yes No Sign.
n = 28 n = 33 n = 35 n = 26
Substance use disorders
AUD only (%) 29 61 * 34 62
DUD only (%) 11 15 9 19
AUD and DUD (%) 61 24 ** 57 19 **
Sedatives (%) 29 15 29 12
Cannabis (%) 64 30 * 57 31
Stimulants (%) 29 6 * 26 4 *
Cocaine (%) 21 9 20 8
Opioids (%) 7 0 6 0
Cigarettes per day (mean number) 12.6 6.7 ** 11.0 7.3
SUD characteristics
Age first SUD (mean years) 18.5 27.9 *** 19.8 28.6 **
Total duration of SUD (mean years) 8.4 5.0 * 7.2 5.7
Number of SUDs (mean) 2.4 1.5 ** 2.3 1.4 **
AUDIT sum score (mean) 13.3 15.1 13.3 15.5
DUDIT sum score (mean) 14.2 8.8 * 13.3 8.5
Notes. All diagnoses are lifetime diagnoses. * p < 0.05; ** p < 0.01; *** p ≤ 0.001.
PD personality disorder, Subthreshold lacking one criterion for the diagnosis, SUD substance use disorder, AUD alcohol use disorder, DUD drug use disorder, AUDIT
Alcohol Use Disorders Identification Test, DUDIT Drug Use Disorders Identification Test, Sign. statistically significant differences between patients with and without PD.
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Of the 61 patients with SUD diagnosis, 11.5% had no
comorbid Axis I or Axis II disorders, 42.6% had a
comorbid Axis I disorder, and the same percentage had
both Axis I and Axis II comorbidity. Only two patients
had an Axis II disorder without a comorbid Axis I dis-
order. Comorbid Axis I disorders were highly prevalent
in SUD patients with and without PDs (Table 4). Only
the most prevalent affective and anxiety disorders are
specified in Table 4. We found a significantly higher
mean number of lifetime Axis I disorders in the PD
group. Of the different anxiety disorders, social phobia
occurred significantly more often in PD patients. There
was no difference in the prevalence of mood disorders;
however, the age at onset of any mood disorder was sig-
nificantly lower in SUD patients with PDs than in SUD
patients without PDs (17.4 years compared to 26.3 years;
p = 0.027). The distribution of independent and substance-
induced major depressive disorder (MDD) did not differ
between groups.
Other assessments
Patients with PDs had a higher symptom load as mea-
sured by the SCL-90-R. There were statistically signifi-
cant differences on all the subscales except Depression,
Somatization, and Additional (mainly measuring pro-
blems with sleep or appetite). The main differences were




n = 28 n = 33
Comorbid Axis I disorders
Any Axis I disordera (%) 93 79
Number of Axis I disordersa (mean) 2.6 1.7
Any mood disorder (%) 79 73
MDD (%) 68 70
Any anxiety disorder (%) 68 36
Social phobia (%) 50 15
Panic disorder (%) 18 6
PTSD (%) 21 15
Other assessments
SCL-90-R, GSI score (mean) 1.45 0.94
IDS sum score (mean) 30.5 22.4
GAF-S (mean score) 51.4 58.8
GAF-F (mean score) 49.5 61.4
Notes. All diagnoses are lifetime diagnoses. a Axis I disorders other than SUDs. * p <
PD personality disorder, Subthreshold lacking one criterion for the diagnosis, SUD su
stress disorder, GAF-S Global Assessment of Functioning, Symptom score, GAF-F Glo
Checklist, 90 Questions, Revised, GSI Global Symptom Index, IDS Inventory of Depre
and without PD.and Phobic Anxiety subscales, and were also statistically
significant after Bonferroni correction. The patients with
comorbid PDs were more depressed, according to the
IDS, and had more severe symptoms and poorer func-
tioning, according to the GAF scores.
The mean age at onset of the different disorders was
low in patients with PDs. Patients with anxiety disorders
had a mean age at onset of nine years, the first SUD had
a mean age at onset of 17 years, and the first affective
disorder occurred at a mean age of 18 years.
We repeated the analyses with the subthreshold diag-
noses included in the PD group (as shown in Tables 3
and 4). This caused a greater increase in the prevalence
of some of the PDs (obsessive-compulsive, paranoid,
dependent, and avoidant) than in others, and Cluster C
diagnoses became as prevalent as Cluster B diagnoses.
In general, the differences between patients with and
without PDs decreased, but there were still statistically
significant differences concerning age, education, em-
ployment, number of SUDs, and scores on the SCL-90-
R, GAF-S, and GAF-F.
Discussion
Prevalence of PDs
The main finding of this study was that about half of the
sample of patients admitted for the first time with SUDs
had a comorbid PD. In most earlier studies of clinical
samples, the prevalence has been estimated to be aroundith substance use disorders with and without comorbid
PD including subthreshold diagnoses
Sign. Yes No Sign.









* 1.37 0.92 *
** 28.0 23.6
*** 53.0 58.7 **
*** 51.5 61.9 ***
0.05; ** p < 0.01; *** p ≤ 0.001.
bstance use disorder, MDD major depressive disorder, PTSD, post-traumatic
bal Assessment of Functioning, Functioning score, SCL-90-R Symptom
ssive Symptoms, Sign. statistically significant differences between patients with
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prevalence of PDs in SUD patients [34]. This study ap-
plied the Millon Clinical Multiaxial Inventory (MCMI-
II), a self-report diagnostic inventory, for assessment of
Axis II diagnoses. The MCMI-II may overestimate the
prevalence of PD diagnoses in SUD patients [35]. The
differences between studies may also be explained by
our inclusion of patients at their first admission only. In
studies of samples that include patients with longer
treatment histories with several readmissions to treat-
ment, a higher proportion of patients are likely to be
more severely and chronically ill. Additionally, in those
patients, the risk of including substance-induced symp-
toms, especially in antisocial or borderline PDs, is higher
[9]. Our findings may be closer to a ‘true’ prevalence, as
we included all treatment seekers from the catchment
area and all treatment modalities, applied reliable diag-
nostic interviews, and controlled for other Axis I and
somatic comorbidities.
Prevalence of subtypes
Consistent with most other studies, we found that Cluster
B PDs were the most prevalent in SUD patients
[11,13,17]. However, the difference between Cluster B and
Cluster C diagnoses in our study was not statistically
significant. When we included subthreshold diagnoses,
Cluster C diagnoses were numerically more prevalent.
Some studies have found PDs other than antisocial PD
and borderline PD to be most prevalent. This may be
explained by sample selection and assessment methods.
The prevalence of PDs in SUD patients is far above
that found in epidemiological studies of PDs. A Norwe-
gian study from the capital, Oslo, found PDs in 13.4%
of the population [36] compared with 46% in our clin-
ical sample. Other studies have found even lower rates
in the general population [37,38]. The selection bias of
hospital wards results in a higher prevalence of comor-
bidity in clinical samples. This is often referred to as
Berkson’s fallacy [39]. When we compared the different
PD diagnoses in our sample with those of a community
sample, we found a particularly high prevalence of anti-
social (16.4% versus 0.7%), borderline (13.1% versus
0.7%), paranoid (8.2% versus 2.4%), obsessive-compul-
sive (8.2% versus 2.0%), and avoidant (8.2% versus 5.0%)
PDs. The prevalence pattern of PDs in SUD patients is
different from the PD pattern found in patients with
other Axis I diagnoses. In patients with mood or anx-
iety disorders, obsessive-compulsive, paranoid, and avoi-
dant PDs are the most prevalent, while antisocial PD is
far less prevalent than in SUD patients [40]. Interest-
ingly, accidentally injured patients admitted to a surgi-
cal department had prevalence rates more similar to
SUD patients [41].Axis I comorbidity
Patients with SUDs and PDs had a higher number of
additional Axis I disorders than SUD patients without
PDs. The low GAF-S scores and the high scores on the
SCL-90-R and IDS indicated higher symptom loads in
patients with PDs. Mood disorders were prevalent, but
there were no differences between the groups. Previous
studies have found more depression in SUD patients
with PDs than in those without PDs [11,18]. Those stud-
ies assessed depressive symptoms in substance users
without using diagnostic interviews reliability-tested in
patients with comorbid disorders. Consistent with other
studies [18], we found higher depressive symptom mea-
sures in PD patients, but we found no significant differ-
ence in the prevalence of MDD.
Anxiety disorders were more prevalent in SUD
patients with PDs than in those without PDs in our
study, consistent with previous studies. Almost 70% of
the SUD patients with PDs had an anxiety disorder, most
often social phobia. The high prevalence of social phobia
in SUD patients [42] and the high prevalence of SUDs in
patients with social phobia [43] indicate that patients
with this disorder may have a disposition towards exces-
sive substance use. The mean age at onset of social pho-
bia was 10.4 years in the patients with PD and 13.2 years
in the patients without PDs. The mean age of onset of
SUDs in these two groups was 20.4 and 41.0 years, re-
spectively, a difference that was statistically significant
(p = 0.018). The combination of social phobia and PD
seems to increase the risk of early onset SUD.
Demographics and functioning
In our study, male and female SUD patients had the
same overall prevalence of PDs. This is consistent with
the previous Norwegian study of Landheim et al. [34].
We found antisocial PD in almost a quarter of the male
patients, but in no female patients. However, Landheim
et al. found the same prevalence of antisocial PD in
women and in men (28% and 32%). In the general popu-
lation in Oslo, Norway, PDs were found in 12.6% of the
women and 13.7% of the men (the difference was not
statistically significant) [36]. Consistent with our study,
they did not find antisocial PD in women. This commu-
nity study found statistically significant differences be-
tween women and men in the prevalence of antisocial
PD (0% versus 1.3%), obsessive-compulsive PD (1.3%
versus 2.6%), and passive-aggressive PD (0.9% versus
2.2%). Other studies have also provided inconsistent find-
ings. In a sample of drug-dependent patients, Kokkevi
et al. found no statistically significant differences between
genders on any PD diagnoses [13]. In a sample of opioid
abusers, Brooner et al. found that women were less likely
than men to have a PD, twice as many males as females
had antisocial PD, and seven times as many females as
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are probably explained by sample selection. In addition,
the very high prevalence of antisocial behavior in the
most severely dependent substance users may be a result
of living with addiction, and not a primary PD.
Patients with SUDs and comorbid PDs were less likely
to attend school or work. The lower GAF-F scores indi-
cated a lower level of functioning in the PD group. Our
finding of more functional impairment in SUD patients
with PDs is consistent with the findings of previous
studies [4,18]. The decrease in differences between
patients with and without PDs when subthreshold diag-
noses are included implies, as expected, that the patients
with subthreshold diagnoses have somewhat better func-
tioning and fewer comorbid disorders than patients who
meet the full criteria.
Age at onset and early intervention
SUD patients with PDs were admitted to treatment for
the first time at an earlier age than SUD patients without
PDs. Patients with PDs developed their first SUDs at an
earlier age, used more substances, and were heavier
users of illicit substances. Childhood personality traits
that make subjects susceptible to substance use, such as
novelty seeking and disinhibition [44], may cause pro-
blems with resisting illicit substances and restricting the
quantity of substances, including nicotine.
Of all the main Axis I diagnostic categories, the anx-
iety disorders had the earliest age at onset (attention def-
icit/hyperactivity disorder excluded), consistent with the
findings of other studies [45]. It has been hypothesized
that anxiety and affective symptoms can be partial med-
iators between childhood trauma and SUDs [46].
Even with the heavy burden of symptoms and impair-
ment at a young age, patients with SUDs and PDs had
their SUDs for several years more than patients without
PDs before seeking treatment. SUD patients with comor-
bid PDs develop their disorders before their nervous sys-
tem has matured [47], and before they have had
experience in coping with adversities and life problems.
This explanation contributes to the understanding of the
poor prognosis. Conduct disorder in childhood is a pre-
cursor of antisocial PD. Conrod et al. found that
personality-targeted interventions in high-risk young ado-
lescents delayed the onset of drinking and binge drinking
[48]. Early intervention, focusing on personality traits and
substance use in young adolescents with conduct disorder,
may restrict the progression into PDs and SUDs.
Outcome studies of samples of SUD patients have
shown that the co-occurrence of PDs has a high negative
predictive value for future abstinence in both AUD and
DUD patients [1,4,49,50]. It has been hypothesized that
this is related to the PD patients’ lower ability to formtreatment alliances [51] or their lower ability to cope
with negative affects [52]. The combination of comorbid
Axis I and Axis II disorders in SUD patients makes the
outcome of the SUDs even more adverse [53,54]. In
addition, the outcome of the PD is worse if the SUD is
not treated [55]. In summary, our findings emphasize
the necessity of diagnosing comorbid Axis I and Axis II
disorders in SUD patients in clinical practice.
Strengths and limitations
The strengths of this study lie in the sample collection
and assessment methods. The catchment-area-based ser-
vices made it possible to identify all patients who met
the study criteria. Other specialized addiction or psychi-
atric services, which received patients from the catch-
ment area, cooperated by identifying eligible patients
and referring them to the study. In contrast to earlier
studies, the PDs in our sample were assessed at a rela-
tively early stage. By selecting a sample of patients at
their first admission, we avoided an overrepresentation
of the chronically ill, and we reduced recall bias. Fur-
thermore, we obtained reliable assessment of all com-
mon SUDs, Axis I, and Axis II disorders, by using
reliability-tested diagnostic interviews performed by a
psychiatrist. The SCID-II was chosen for its good criter-
ion validity and reliability in diagnosing PDs. The PRISM
is the best-documented diagnostic interview for diagnos-
ing a wide range of Axis I disorders in heavy substance
users. The use of different methods to assess some of
the same symptom areas showed consistent results. This
strengthens the findings. SUD patients are at high risk of
noncompliance. Even so, we had a low dropout rate of
four out of 78 (5%), which was achieved by the personal
follow-up of each patient.
The limitations of this study lie in the relatively small
sample size, and the risk of type II errors. On the other
hand, the statistically significant differences found when
comparing small groups are reliable and interesting. The
small sample size is due to the rigid inclusion rules: a sin-
gle catchment area and the use of patients on their first
admission only. Choosing a larger catchment area would
have increased the sample size, but at the cost of losing
the overview of all eligible patients. Some of the patients
were using psychoactive substances during the interview-
ing period; there was no defined period of abstinence be-
fore the assessments. This may have influenced the
patients’ statements and memory. However, the patients
were interviewed in a stable phase, each patient was seen
at several appointments, and inconsistencies were
attended to. We did not account for multiple testing.
Conclusions
Almost half of this representative sample of SUD
patients, admitted for treatment for the first time, had
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ited to antisocial and borderline PD. SUD patients with
PDs differ from those without PDs. They have a lower
age at admission, a lower age at onset of their first SUD,
more use of illicit drugs, more anxiety disorders, lower
ability to attend work or school, more distressing symp-
toms, and more functional impairment. Thus, SUD
patients with PDs have different treatment needs than
SUD patients without PDs. SUD patients should there-
fore be thoroughly assessed for comorbid Axis I and
Axis II disorders.
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